Hepatitis C in Poland in 2021.

Q3 Medicine
Karolina Zakrzewska, Małgorzata M Stępień, Magdalena Rosińska
{"title":"Hepatitis C in Poland in 2021.","authors":"Karolina Zakrzewska,&nbsp;Małgorzata M Stępień,&nbsp;Magdalena Rosińska","doi":"10.32394/pe.77.21","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In 2021, the COVID-19 pandemic continued, however, due to the implementation of vaccination, fewer disruptions were observed in healthcare. In the detection of HCV - inextricably linked to access to testing - there was an incomplete return to the pre-pandemic level of diagnostics (in the EU/EEA in 2021, 4.1 infections/100,000, in 2019 - 8.8). The aim of the article was to present the HCV situation in 2021 according to the data of the epidemiological surveillance in Poland compared to 2015-2020.</p><p><strong>Material and methods: </strong>We used the data: 1) from individual epidemiological surveillance; 2) from bulletins for the years 2015-2021 (diagnosis rates) and 3) regarding deaths from the Statistics Poland, Demographic Surveys and Labour Market Department.</p><p><strong>Results: </strong>In 2021, a 30% increase in the detection of new HCV infections was observed (3.26/100,000, 1,244 cases) - about 70%, more than 2,500 cases, are missing to return to the pre-pandemic level. The demographic distribution was different than in Europe: 1) the ratio of women to men 1:1.07; 2) people <25 years: 2.4% of all diagnoses - this may imply worse access to testing among men than women (tested during pregnancy), especially in younger age groups. In Poland, a large percentage of diagnoses involves people outside the high- risk population - mainly exposures related to medical procedures (>75%). The role of primary health care in diagnosing HCV has strengthened (38.6%) - despite the fact that the tests were not yet available within health insurance benefits. The burden on healthcare and sanitary inspection continued to reduce the quality of data. There were more deaths due to acute hepatitis C in 2020-2021 (4 and 6 cases) compared to 2018 2019 (0 and 1 death).</p><p><strong>Conclusions: </strong>The highlighted gaps in diagnosing HCV infections in Poland should be taken into consideration while developing the policy for HCV infections elimination. Poland still lacks in long term solutions, acceptable by and reaching the target population.</p>","PeriodicalId":20777,"journal":{"name":"Przeglad epidemiologiczny","volume":"77 2","pages":"220-232"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Przeglad epidemiologiczny","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32394/pe.77.21","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: In 2021, the COVID-19 pandemic continued, however, due to the implementation of vaccination, fewer disruptions were observed in healthcare. In the detection of HCV - inextricably linked to access to testing - there was an incomplete return to the pre-pandemic level of diagnostics (in the EU/EEA in 2021, 4.1 infections/100,000, in 2019 - 8.8). The aim of the article was to present the HCV situation in 2021 according to the data of the epidemiological surveillance in Poland compared to 2015-2020.

Material and methods: We used the data: 1) from individual epidemiological surveillance; 2) from bulletins for the years 2015-2021 (diagnosis rates) and 3) regarding deaths from the Statistics Poland, Demographic Surveys and Labour Market Department.

Results: In 2021, a 30% increase in the detection of new HCV infections was observed (3.26/100,000, 1,244 cases) - about 70%, more than 2,500 cases, are missing to return to the pre-pandemic level. The demographic distribution was different than in Europe: 1) the ratio of women to men 1:1.07; 2) people <25 years: 2.4% of all diagnoses - this may imply worse access to testing among men than women (tested during pregnancy), especially in younger age groups. In Poland, a large percentage of diagnoses involves people outside the high- risk population - mainly exposures related to medical procedures (>75%). The role of primary health care in diagnosing HCV has strengthened (38.6%) - despite the fact that the tests were not yet available within health insurance benefits. The burden on healthcare and sanitary inspection continued to reduce the quality of data. There were more deaths due to acute hepatitis C in 2020-2021 (4 and 6 cases) compared to 2018 2019 (0 and 1 death).

Conclusions: The highlighted gaps in diagnosing HCV infections in Poland should be taken into consideration while developing the policy for HCV infections elimination. Poland still lacks in long term solutions, acceptable by and reaching the target population.

2021年波兰丙型肝炎。
背景:2021年,新冠肺炎大流行仍在继续,但由于实施了疫苗接种,在医疗保健方面观察到的干扰较少。在丙型肝炎病毒的检测中,与检测密不可分,诊断水平没有完全恢复到大流行前的水平(2021年欧盟/欧洲经济区,感染率为4.1/10万,2019年为8.8)。文章的目的是根据波兰与2015-2020年相比的流行病学监测数据,介绍2021年的丙型肝炎病毒情况。材料和方法:我们使用了数据:1) 来自个体流行病学监测;2) 来自2015-2021年波兰统计局、人口调查和劳动力市场部关于死亡的公告(诊断率)和3)。结果:2021年,新的丙型肝炎病毒感染检测增加了30%(3.26/100001244例),约70%,即2500多例,没有恢复到大流行前的水平。人口分布与欧洲不同:1)男女比例为1:1.07;2) 75%的人)。初级卫生保健在诊断丙型肝炎病毒中的作用得到了加强(38.6%),尽管事实上,在医疗保险福利范围内还没有这种检测。医疗保健和卫生检查的负担继续降低数据质量。与2018年至2019年(0例和1例死亡)相比,2020-2021年因急性丙型肝炎死亡的人数更多(4例和6例)。结论:在制定消除丙型肝炎感染的政策时,应考虑波兰在诊断丙型肝炎病毒感染方面的突出差距。波兰仍然缺乏能够被目标人口接受并达到目标人口的长期解决方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Przeglad epidemiologiczny
Przeglad epidemiologiczny Medicine-Medicine (all)
CiteScore
1.10
自引率
0.00%
发文量
64
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信